Picture of Biomerieux SA logo

BIM Biomerieux SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Top of the Street: Deutsche Bank, Commerzbank, UniCredit

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Goldman Sachs downgrades Germany's Deutsche Bank DBKGn.DE to "neutral" from "buy" and Commerzbank to "sell" from "neutral" based on their high valuation and significant year-to-date outperformance

INITIATIONS AND REINSTATEMENTS

** Citigroup resumes coverage of Italy's second-largest bank UniCredit CRDI.MI with a "buy" rating on higher earnings forecasts and potential M&A opportunities

** J.P. Morgan initiates coverage of bioMérieux BIOX.PA with a "neutral" rating, saying the company's strengths and growth prospects are already priced in the stock

** J.P. Morgan initiates coverage on Italian medical diagnostics group DiaSorin DIAS.MI at "underweight" with a 75.40 euros ($88.27) price target, citing structural challenges and limited scope for margin progression

(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

 (Reporting by Alessandro Parodi and Olivier Cherfan)

 ((Alessandro.Parodi@thomsonreuters.com;))

Recent news on Biomerieux SA

See all news